Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways

Publication date: September 2021Source: Biomedicine & Pharmacotherapy, Volume 141Author(s): Weixin Zhao, Yixiao Yan, Zhongxiang Xiao, Meihong Wang, Mingjiang Xu, Zhe Wang, Yi Wang, Zaishou Zhuang, Daona Yang, Gaozhi Chen, Guang Liang
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research